Has Jason Miller, MD received payments from drug or device companies?

Yes. Drug and device makers reported $47,952 in general payments to Jason Miller, MD across 55 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jason Miller, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jason Miller, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jason Miller, MD

Podiatrist · Kingwood, TXNPI 1164411021

Payments from drug & device makers

What this record shows

This record is dominated by other: $40,052 of the $47,952 with a category attached, or 83.5%. Medshape, Inc. accounts for 83.5% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2021 at $43,263 and has fallen 99.2% since, to $353 in 2025. Among podiatrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$47,952in general payments, 2019–2025

Across 55 payments — averaging $871.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medshape, Inc.$40K
DNE LLC$3K
Restor3d, Inc.$3K
Stryker$614
Sanara Medtech Inc.$277
Smith+Nephew$258
plus $1K from 20 others

What the payments were for

Royalty or licence$2,5775%
Travel & lodging$1,2003%
Food & beverage$4,1239%
Other$40,05284%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medshape, Inc.	1	$40,052
DNE LLC	2	$2,782
Restor3d, Inc.	1	$2,577
Stryker	11	$614
Sanara Medtech Inc.	2	$277
Smith+Nephew	2	$258
Trilliant Surgical LLC.	2	$229
Zimmer Biomet	4	$160
Musculoskeletal Transplant Foundation Inc.	2	$144
Bone Support Inc.	1	$121
Medtronic	3	$103
Wound Management Technologies, Inc	2	$94
Celularity Inc.	2	$76
Melinta Therapeutics, LLC	2	$60
Bioventus LLC	3	$58
Kowa Pharmaceuticals America, Inc.	1	$45
Baudax Bio Inc.	2	$45
Acera Surgical, Inc.	2	$40
Treace Medical Concepts, Inc.	2	$40
Encore Medical, LP	1	$37
AstraZeneca	2	$28
Pacira Pharmaceuticals Incorporated	1	$25
Biotissue Holdings Inc.	1	$24
Integra Lifesciences Corporation	1	$22
Heron Therapeutics, Inc.	1	$21
Johnson & Johnson	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$47,952 in reported general payments places this provider in the 95th percentile of 470 podiatrist providers in Texas.

See all podiatrist providers in Texas →

Medicare billing

Part B allowed, 2024

$47,798

Medicare patients

148

Services billed

822

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	14	$134
Gabapentin	13	$110

Paid to pharmacies, not to this prescriber.

Other podiatrist in Kingwood

Brian CarpenterFort Worth$1.2M
Gary LepowHouston$1M
Wayne HurstCedar Park$625K
Calvin RushingSunnyvale$452K
Alan GarrettFort Worth$185K
Gregory JarygaFt Worth$175K
Brandon LampeMesquite$154K
Andrew SchneiderHouston$150K
Patrick BriggsWebster$133K
Richard AdamsGranbury$130K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →